Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Towa Pharmaceutical Total Assets (Quarterly) : 2.958B for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.958B |
| March 31, 2026 | 2.988B |
| December 31, 2025 | 3.119B |
| September 30, 2025 | 3.254B |
| June 30, 2025 | 3.290B |
| March 31, 2025 | 3.148B |
| December 31, 2024 | 2.921B |
| September 30, 2024 | 3.096B |
| June 30, 2024 | 2.805B |
| March 31, 2024 | 2.846B |
| December 31, 2023 | 2.941B |
| September 30, 2023 | 2.633B |
| June 30, 2023 | 2.727B |
| March 31, 2023 | 2.790B |
| December 31, 2022 | 2.708B |
| September 30, 2022 | 2.430B |
| June 30, 2022 | 2.733B |
| March 31, 2022 | 2.736B |
| December 31, 2021 | 2.223B |
| September 30, 2021 | 2.267B |
| June 30, 2021 | 2.245B |
| March 31, 2021 | 2.223B |
| December 31, 2020 | 2.302B |
| September 30, 2020 | 2.250B |
| June 30, 2020 | 2.272B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.131B |
| December 31, 2019 | 1.780B |
| September 30, 2019 | 1.779B |
| June 30, 2019 | 1.753B |
| March 31, 2019 | 1.709B |
| December 31, 2018 | 1.638B |
| September 30, 2018 | 1.550B |
| June 30, 2018 | 1.573B |
| March 31, 2018 | 1.667B |
| December 31, 2017 | 1.574B |
| September 30, 2017 | 1.520B |
| June 30, 2017 | 1.482B |
| March 31, 2017 | 1.483B |
| December 31, 2016 | 1.415B |
| September 30, 2016 | 1.605B |
| June 30, 2016 | 1.512B |
| March 31, 2016 | 1.396B |
| December 31, 2015 | 1.218B |
| September 30, 2015 | 1.204B |
| June 30, 2015 | 1.059B |
| March 31, 2015 | 1.011B |
| December 31, 2014 | 963.54M |
| September 30, 2014 | 961.60M |
| June 30, 2014 | 996.51M |
| March 31, 2014 | 1.003B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 96.37B |
| Daiichi Sankyo Co., Ltd. | 25.32B |
| Eisai Co., Ltd. | 9.587B |
| Chugai Pharmaceutical Co., Ltd. | 15.07B |
| Santen Pharmaceutical Co., Ltd. | 2.559B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.835B |
| Shareholders Equity (Quarterly) | 1.123B |
| Debt to Equity Ratio | 1.26 |
| Current Ratio | 2.821 |
| Net Debt Paydown Yield | 2.08% |